Found 14892 matches for
A new statement has been released from Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY Trial. RECOVERY was established in March as a randomised clinical trial to test a range of potential drugs for COVID-19, including hydroxycholoroquine. The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. The chief investigators have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19.
Information about Student Wellbeing and Support Services, includes relevant links
Information for staff about Wellbeing and Support Services, includes relevant links
Slide of Rogier van Doorn presentation for TropMed webinar on AMR surveillance, October 2020
PDF slides of Paul Turner from our COMRU unit in Cambodia telling us about the pressing need for quality laboratory data in low and middle income countries, for better antimicrobial resistance surveillance. TropMed webinar on AMR surveillance, October 2020